Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06375395
Other study ID # Memory Updating Tasks
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date May 15, 2024
Est. completion date December 31, 2024

Study information

Verified date November 2023
Source Xuanwu Hospital, Beijing
Contact Hongxing Wang, MD & PhD
Phone 01083198513
Email hxwang8888@126.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objectives of this study include: 1) investigating the impact of negative memory substitution on an individual's other intellectual memories (i.e., neutral memories) and the underlying neurocognitive mechanisms; 2) investigating the memory enhancement effect resulting from retrieval practice associated with memory substitution intervention along with an examination of the neurocognitive mechanisms responsible for this enhancement.


Description:

This study will adopt two memory updating strategies: retrieval practice and reactivation. A 5-day memory updating experimental paradigm is used. 1. On the first day, the old memory A-B linkage is learned, where A represents a neutral word and B is either neutral or negative pictures (half of each, randomly scrambled). 2. On the second day, the old memory A-B association is consolidated again, and after a 15-minute break, the new memory A-C association is learned, where A is still the word A used in the old memory A-B association on the first day, and C is the new neutral and negative pictures (half of each, randomly scrambled, and with inconsistent categories of C and B in each pair of AC and AB). Immediately following this, the new memories of the A-C conjunctions are updated using both Retrieval practice and Restudy (control condition) memory strategies. 3. A-C is extracted/learned using both Retrieval practice and Restudy memory strategies on both day 3 and day 4. 4. On the fifth day, memory tests for associative memory strength, gist and detail memory, as well as emotional valence and strength are performed.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 60
Est. completion date December 31, 2024
Est. primary completion date December 15, 2024
Accepts healthy volunteers No
Gender All
Age group 14 Years to 60 Years
Eligibility Eligibility Inclusion Criteria: 1. 14-60 years old, male or female, Han Chinese; 2. Drug-resistant epilepsy; 3. Required surgical implantation of SEEG electrodes. Exclusion Criteria: 1. Progressive encephalopathy or progressive structural damage in the central nervous system; 2. Significant heart, liver, renal insufficiency, and other medical diseases; 3. Severe side effects from taking antiepileptic drugs at the time of enrollment and not inappropriate for SEEG; 4. Significant intellectual disability; 5. A history of alcohol and drug abuse; 6. Any contraindication to MRI.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Active tACS Device
Transcranial Alternating Current Stimulation
Sham tACS Device
Placebo Device that simulates active tACS treatment

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Xuanwu Hospital, Beijing Beijing Normal University

Outcome

Type Measure Description Time frame Safety issue
Primary Negative memory retention The intervention could disrupt retention of associative negative memory and degree of detail of the negative memories in last A-C paired associate memory test. Day 5
Secondary The negative emotional intensity of negative memory The negative memories emotional relief as assesses by the Self-Assessment Manikin (SAM) Measure Scales in last A-C paired associate memory test.
This measure is constant retrieval practice of neutral memories (A-Cneu) will result in negative memories emotional relief (A-Bneg) compared to the restudy condition.
Day 5
Secondary The retention of associated neutral memories as assesses by the proportions of responses of correctly choosing picture category of B picture (A-Bneu) in last A-B paired associate memory test This measure is continuous rumination of negative memories (A-Cneg) will increase the strength of associated memories (A-Bneu). Day 5
Secondary The negative emotional intensity of neutral memory The emotion-diffusing effects of negative memory rumination as assesses by negative emotional intensity of neutral memories (A-Bneu),which is meature by the Self-Assessment Manikin (SAM) Measure Scales. The negative emotional intensity of neutral memories are more negative with constant retrieval practice of negative memories (A-Cneg) that is the emotion-diffusing effects of negative memory rumination. Day 5
See also
  Status Clinical Trial Phase
Recruiting NCT02850913 - Doxycycline for the Treatment of Nodding Syndrome Phase 2
Recruiting NCT04076449 - Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy
Not yet recruiting NCT06045676 - Electrocardiographic Changes Among Epileptic and Non Epileptic Seizures in Children at Sohag University Hospital
Completed NCT03722212 - Early Diagnosis of the GLUT1 Deficiency Syndrome With a Blood Based Test N/A
Not yet recruiting NCT05649891 - Checklists Resuscitation Emergency Department N/A
Completed NCT02897856 - Efficacy and Safety of Intramuscular Midazolam Compared to Buccal Midazolam in Pediatric Seizures Phase 4
Completed NCT01239212 - Dosing of Levetiracetam (Keppra) in Neonates Phase 1/Phase 2
Completed NCT01236001 - Belgian Drug-utilization Study to Evaluate the Use of VIMPAT® as Adjunctive Treatment of Partial Onset Seizures in Subjects Aged 16 and Older N/A
Completed NCT01702623 - Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fasted Conditions Phase 1
Completed NCT01703468 - Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fed Conditions Phase 1
Recruiting NCT02216500 - Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy N/A
Completed NCT00236717 - A Study of the Effectiveness and Safety of Topiramate Compared With a Standard Therapy in Patients Newly Diagnosed With Epilepsy Phase 3
Terminated NCT03954314 - DEPOSITION - Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac Surgery Phase 3
Completed NCT05103735 - Propofol-remifentanyl Versus Dexmedetomidine in Awake Craniotomy: Impact on Electroclinical Seizure Activity
Terminated NCT03790436 - Betaquik as an Adjunct to Dietary Management of Epilepsy in Adults on the Modified Atkins Diet N/A
Recruiting NCT02552511 - Epidemiology Study on Neonatal Seizure
Recruiting NCT05339126 - RNS System LGS Feasibility Study Phase 2
Active, not recruiting NCT04595786 - The Safety of Intravenous Tranexamic Acid in Patients Undergoing Supratentorial Meningiomas Resection N/A
Recruiting NCT04770337 - Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy N/A
Completed NCT01855178 - Pediatric Seizure Movement Bed Alarm N/A